DELHI, India — Naveen-ul-Haq is set to return to international cricket after being included in Afghanistan’s 15-member squad for the upcoming three-match T20I series against India. The series will also mark Ibrahim Zadran’s first assignment as Afghanistan’s T20I captain.
लेखक: Praveen Yadav
Dhruv Jurel’s Century and Late Wickets Put Sri Lanka on the Back Foot
COLOMBO, Sri Lanka — India took firm control of the second Test against Sri Lanka on Day 2 after Dhruv Jurel’s unbeaten 115 powered the visitors to 503 for 9 declared. Sri Lanka’s reply then suffered an immediate setback, with Lahiru Udara and nightwatchman Prabath Jayasuriya dismissed as the hosts ended the rain-affected day at 8 for 2.
India vs Sri Lanka 2nd Test: Dhruv Jurel’s 115 Powers India to 503/9 as Sri Lanka Slip to 8/2
COLOMBO, Sri Lanka — India moved into a commanding position in the second Test at the Sinhalese Sports Club after Dhruv Jurel’s second Test century helped them declare at 503/9. Sri Lanka were reduced to 8/2 from three overs by the close, leaving the hosts 495 runs behind.
EU Approves €6.1 Billion Ukraine Defence Aid
BRUSSELS, Belgium — The European Commission on Monday approved a further €6.1 billion ($7.12 billion) in financial assistance for Ukraine’s defence needs, as the European Union expands its support amid intensified Russian attacks. The latest package is intended to help Ukraine procure equipment needed to strengthen its defensive capabilities.
Zelenskiy Denies Ukraine Role in Nord Stream Blasts
KYIV, Ukraine — Ukraine had no role in the explosions that damaged the Nord Stream gas pipelines in September 2022, President Volodymyr Zelenskiy said on Sunday. Speaking to reporters in Kyiv, Zelenskiy said Ukraine had never officially participated in any operation involving the destruction of the Nord Stream 2 pipeline.
China Weight-Loss Drug Market Faces Ad Test
SHANGHAI, China — Drugmakers competing in China’s rapidly expanding weight-loss market are promoting obesity awareness through metro stations, gyms, social media and sporting events, even as regulations prohibit direct-to-consumer advertising of prescription medicines. The campaigns by companies including Novo Nordisk, Eli Lilly, Pfizer and Innovent Biologics are drawing attention from experts who say some messaging could come close to crossing the line into drug advertising.